The Vivitrol Marketing Intern will support execution of marketing strategies for the Vivitrol Marketing Team, reporting directly to the Associate Director for Market Development and Brand Strategy. Vivitrol is an injectable product approved by the FDA for the treatment of alcohol dependence or the prevention of relapse to opioid dependence.
Projects may include: Coordinating with analytics teams to identify relevant sales/market trends in key territories; building pivots and graphs to uncover and communicate key insights; supporting sales/marketing strategy meetings; supporting the execution of digital marketing to selected geographies or customer groups; working to streamline materials management and fulfillment for the field; supporting annual brand planning process.
The selected candidate will experience a highly cross-functional environment and contribute to a patient-centric product team. (S)He will gain exposure to content development, to the promotional content review process, to digital marketing, and to the process of developing a comprehensive brand plan. The intern will engage with functions including Marketing, Commercial Operations, Sales, Analytics, Patient Access Services, and external vendors.
This internship encourages and requires consideration of a multitude of stakeholder viewpoints before arriving at a recommendation. Opportunity to build presentation skills may be found based on the candidate’s level of interest and ability.
Basic Qualifications:
Preferred Qualifications:
Working Conditions:
The hourly rate for this position ranges from $21/hr to $24/hr. Exact compensation may vary based on skills, training, knowledge, and experience. Additional details can be found on our careers website: www.alkermes.com/careers#working-here
Why join Team Alkermes?
Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.
We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts’ Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.
Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.